{
 "@context": "https://clearank.com/llms.txt",
 "@type": "clearank:AssetAnalysis",
 "url": "https://clearank.com/stock/centene-cnc/",
 "dataUrl": "https://clearank.com/stock/centene-cnc/data.json",
 "title": "Centene (CNC) Stock Forecast & Price Target (2026)",
 "description": "Centene Corp. (CNC) stock: Healthcare, Healthcare Plans. $31.6B market cap. AI rating, technicals, 2030 forecast and trade plans.",
 "headline": "Centene Corp. (CNC)",
 "published": "2026-07-26T09:19:58+00:00",
 "modified": "2026-09-10T09:13:29.167+00:00",
 "generated": "2026-09-11T20:40:30.566Z",
 "language": "en-US",
 "publisher": {
  "name": "CleaRank",
  "url": "https://clearank.com/"
 },
 "disclaimer": "Educational and informational only; not financial advice. AI-generated analysis reviewed by the CleaRank editorial team; prices delayed up to 15 minutes.",
 "asset": {
  "ticker": "CNC",
  "name": "Centene Corp.",
  "type": "Common Stock",
  "exchange": "NYSE",
  "currency": "USD",
  "sector": "Healthcare",
  "industry": "Healthcare Plans",
  "country": "United States",
  "website": "https://www.centene.com"
 },
 "quote": {
  "price": 65.4,
  "previousClose": 64.06,
  "change": 1.34,
  "changePercent": 2.09,
  "open": 65.5,
  "high": 68.205,
  "low": 65.33,
  "volume": 4615623,
  "averageVolume": 4431262,
  "marketCap": 31645318712,
  "fiftyTwoWeekHigh": 69.36,
  "fiftyTwoWeekLow": 28.24,
  "marketOpen": false,
  "asOf": "2026-09-10T09:13:28.000Z"
 },
 "statistics": {
  "pe": -6.31,
  "eps": -10.36,
  "dividendYield": 0,
  "beta": 1.106,
  "priceToSales": 0.17940141,
  "priceToBook": 1.4336698,
  "revenueTtm": 180304003072,
  "grossMargin": 0.08587319658821553,
  "returnOnEquity": -0.20358999
 },
 "technicals": {
  "rsi": 47.32,
  "macd": 0.18,
  "sma50": 65.5,
  "sma200": 50.61,
  "rsiSignal": "Neutral",
  "trend": "Bullish",
  "pricePosition": "Bearish",
  "macdSignal": "Bullish",
  "rating": "Neutral"
 },
 "analysis": {
  "rating": "Hold",
  "score": 59,
  "consensus": "Hold",
  "fairValue": 70.5,
  "analystTarget": 70.5,
  "analystCount": 21,
  "wallStreetConsensus": "Hold",
  "generatedAt": "2026-09-10T09:13:28.000Z",
  "priceAtAnalysis": 65.4,
  "volatility": {
   "daily": 2.22,
   "risk": "standard"
  }
 },
 "tradePlan": {
  "bias": "Neutral",
  "conservativeEntry": 64.75,
  "aggressiveEntry": 65.4,
  "stopLoss": 60.21,
  "stopLossPercent": 7,
  "targets": [
   66.69,
   67.98,
   69.93
  ]
 },
 "projections": {
  "basis": "Monte Carlo simulation on historical return distribution, re-run daily; not price targets",
  "years": [
   {
    "year": 2027,
    "downside10th": 41.8,
    "base": 69.88,
    "upside90th": 116.81
   },
   {
    "year": 2028,
    "downside10th": 36.1,
    "base": 74.66,
    "upside90th": 154.41
   },
   {
    "year": 2029,
    "downside10th": 32.76,
    "base": 79.77,
    "upside90th": 194.25
   },
   {
    "year": 2030,
    "downside10th": 30.5,
    "base": 85.23,
    "upside90th": 238.18
   },
   {
    "year": 2031,
    "downside10th": 28.86,
    "base": 91.06,
    "upside90th": 287.3
   },
   {
    "year": 2032,
    "downside10th": 27.64,
    "base": 97.3,
    "upside90th": 342.54
   },
   {
    "year": 2033,
    "downside10th": 26.7,
    "base": 103.96,
    "upside90th": 404.82
   },
   {
    "year": 2034,
    "downside10th": 25.97,
    "base": 111.07,
    "upside90th": 475.09
   },
   {
    "year": 2035,
    "downside10th": 25.4,
    "base": 118.68,
    "upside90th": 554.4
   },
   {
    "year": 2036,
    "downside10th": 24.97,
    "base": 126.8,
    "upside90th": 643.85
   }
  ]
 },
 "faqCount": 8,
 "sources": [
  "TwelveData",
  "Wall Street consensus"
 ],
 "sections": [
  {
   "id": "price",
   "title": "CNC Price Analysis"
  },
  {
   "id": "market-metrics",
   "title": "Market Metrics",
   "facts": {
    "Open": "$65.50",
    "Day Range": "$65.33 to $68.21",
    "Prev Close": "$64.06",
    "Volume": "4.62M",
    "52-Week Range": "$28.24 to $69.36",
    "Market Cap": "$31.65B"
   }
  },
  {
   "id": "peer-benchmarking",
   "title": "Peer Benchmarking",
   "text": [
    "Sector Position Analysis Trading at a notable discount to sector peers (-68%), which may indicate undervaluation or specific company headwinds."
   ]
  },
  {
   "id": "financials",
   "title": "CNC Financial Performance",
   "text": [
    "Analysis: In the last 3 quarters, CNC beat estimates 3 times. The stock rose 2 times the next day. Price tends to react positively to beats."
   ]
  },
  {
   "id": "analysis",
   "title": "CNC Analysis",
   "text": [
    "Centene Corp. (CNC) exhibits neutral momentum with an RSI of 47.32, indicating neither overbought nor oversold conditions. The stock is trading below its 50-day SMA of $65.50 and its 20-day EMA of $65.44, suggesting short-term weakness, although it remains above its 200-day SMA of $50.61. MACD is slightly positive at 0.178, hinting at a potential shift but lacking strong conviction. Volume has been slightly above average recently, with the latest volume at 4.48 million compared to an average of 4.33 million. The chart structure indicates that the 50-day SMA is acting as resistance, while the 200-day SMA is providing support. The current price action suggests a period of consolidation or a potential downtrend initiation if the 200-day SMA is breached. Investors should monitor the 50-day SMA closely as a key level to watch for a potential shift in short-term momentum.",
    "Centene Corp. (CNC) is forecasting revenue decreases in the current quarter (-6.00% YoY) and next quarter (-9.00% YoY), indicating potential market share loss or pricing pressures.",
    "Insiders have sold a net of over $14 million in Centene Corp. (CNC) stock, with total sales significantly outweighing total purchases, signaling potential concerns from management.",
    "Centene Corp. (CNC) beat EPS estimates by 6.02% in its most recent reported quarter, demonstrating an ability to outperform analyst expectations.",
    "Centene Corp. (CNC) is currently trading above its 200-day SMA of $50.61, indicating a longer-term upward trend remains intact despite recent choppiness.",
    "Centene Corp. (CNC) is expected to navigate a challenging period in the next 6-12 months, with a base case scenario reflecting its current 'Hold' consensus and limited upside to the median analyst target of $70.50. The projected revenue declines in the near term will likely temper significant stock appreciation, and the company will need to demonstrate a clear path to reversing this trend to attract stronger investor sentiment. The current trading price of $64.06 suggests that the market is pricing in some of these headwinds. Potential catalysts for upside include a stronger-than-expected earnings performance that reverses the negative revenue trajectory or a significant improvement in the company's competitive positioning within the healthcare market. Conversely, continued revenue contraction, persistent insider selling, or a deterioration in the company's profitability could push the stock towards its downside targets. Investors should monitor upcoming earnings reports and management commentary for signs of a turnaround."
   ],
   "lists": {
    "ProTips": [
     "Monitor upcoming earnings reports closely for any signs of revenue stabilization or growth reversal, as this is a key factor for Centene Corp.'s (CNC) future performance.",
     "Given the 'Hold' consensus and limited upside to the median price target, consider waiting for a clearer bullish signal or a more attractive entry point before initiating a significant position in CNC.",
     "The moderate insider selling trend at Centene Corp. (CNC) warrants attention; a significant increase in insider purchases could signal renewed confidence from management."
    ]
   },
   "catalysts": [
    {
     "type": "Bearish",
     "title": "Projected Revenue Declines",
     "text": "Centene Corp. (CNC) is forecasting revenue decreases in the current quarter (-6.00% YoY) and next quarter (-9.00% YoY), indicating potential market share loss or pricing pressures.",
     "source": "Wall Street Revenue Estimates"
    },
    {
     "type": "Bearish",
     "title": "Moderate Insider Selling",
     "text": "Insiders have sold a net of over $14 million in Centene Corp. (CNC) stock, with total sales significantly outweighing total purchases, signaling potential concerns from management.",
     "source": "Insider Summary"
    },
    {
     "type": "Bullish",
     "title": "Positive Earnings Surprise in Latest Quarter",
     "text": "Centene Corp. (CNC) beat EPS estimates by 6.02% in its most recent reported quarter, demonstrating an ability to outperform analyst expectations.",
     "source": "Earnings Recent"
    },
    {
     "type": "Neutral",
     "title": "Trading Above 200-Day Moving Average",
     "text": "Centene Corp. (CNC) is currently trading above its 200-day SMA of $50.61, indicating a longer-term upward trend remains intact despite recent choppiness.",
     "source": "Technical Analysis"
    }
   ]
  },
  {
   "id": "key-statistics",
   "title": "Key Statistics",
   "text": [
    "Centene Corp. (CNC) presents a complex fundamental picture, with a negative EPS of -10.36 rendering traditional P/E ratio analysis impossible. The company's revenue growth stands at 4.6%, which lags behind the sector average of 10.00%. This slower top-line expansion, coupled with projected revenue declines in the upcoming quarters, raises concerns about the company's ability to grow effectively within the competitive healthcare landscape. The market capitalization of $31.65 billion indicates a large-cap entity, but its current financial trajectory requires careful scrutiny. The negative EPS suggests profitability challenges. The sector averages for ROE (15.00%) and P/S (4.20) provide a benchmark, but CNC's current performance metrics do not align favorably. Investors should focus on the company's ability to reverse its revenue decline and improve its earnings to justify its current market valuation.",
    "Centene Corp. (CNC) has demonstrated a volatile earnings history, with the most recent quarter ending July 23, 2026, showing an EPS of $3.52, beating estimates by 6.02% but resulting in a slight price decrease of -0.52%. Prior quarters show a significant beat in April 2026 ($3.37 actual vs. $2.13 estimate, +58.22% surprise) and an even larger beat in March 2026 ($0.15 actual vs. $0.06 estimate, +150% surprise), followed by a price drop of -3.82%. However, the quarter ending May 29, 2026, saw a beat of 24.32% with a positive price reaction of 4.03%. This inconsistency in performance and market reaction suggests that investors may be hesitant to price in sustained earnings strength.",
    "Centene Corp. (CNC) faces significant risks stemming from moderate insider selling, with total sales exceeding purchases by over $14 million. Also, the company is projecting revenue declines in the current and next quarters, indicating potential headwinds to top-line growth. The inconsistent earnings performance and mixed analyst sentiment also contribute to uncertainty regarding the company's future trajectory."
   ],
   "tables": [
    {
     "caption": "",
     "columns": [],
     "rows": [
      {
       "label": "Market Cap",
       "cells": [
        "31.65B"
       ]
      },
      {
       "label": "P/E Ratio",
       "cells": [
        "N/A (Negative EPS)"
       ]
      },
      {
       "label": "EPS (TTM)",
       "cells": [
        "-10.36"
       ]
      },
      {
       "label": "Dividend Yield",
       "cells": [
        "0.00%"
       ]
      },
      {
       "label": "52 Week High",
       "cells": [
        "69.36"
       ]
      },
      {
       "label": "52 Week Low",
       "cells": [
        "28.24"
       ]
      }
     ]
    }
   ]
  },
  {
   "id": "technical-indicators",
   "title": "Technical Indicators",
   "text": [
    "Technical Rating Neutral RSI Neutral SMA Cross Bullish Price vs SMA Bearish MACD Bullish Golden Cross in effect with the 50-day SMA ($65.50) above the 200-day SMA ($50.61), price is trading below the 50-day SMA."
   ],
   "facts": {
    "RSI": "Neutral",
    "SMA Cross": "Bullish",
    "Price vs SMA": "Bearish",
    "MACD": "Bullish"
   },
   "tables": [
    {
     "caption": "",
     "columns": [],
     "rows": [
      {
       "label": "RSI (14)",
       "cells": [
        "47.32"
       ]
      },
      {
       "label": "MACD",
       "cells": [
        "0.18"
       ]
      },
      {
       "label": "SMA 50",
       "cells": [
        "65.50"
       ]
      },
      {
       "label": "SMA 200",
       "cells": [
        "50.61"
       ]
      }
     ]
    }
   ]
  },
  {
   "id": "correlations",
   "title": "Market Correlations",
   "text": [
    "How this stock moves relative to other assets",
    "Based on 1 year of daily price data. Correlations may vary over different time periods."
   ],
   "facts": {
    "Correlation with S&P 500 (SPY)": "+0.05",
    "Correlation with Nasdaq 100 (QQQ)": "+0.01",
    "Correlation with Bitcoin (BTC)": "+0.08",
    "Correlation with Gold (XAU)": "-0.03"
   }
  },
  {
   "id": "trade-plans",
   "title": "CNC Trade Plans",
   "text": [
    "Specific entry, exit, and risk management levels",
    "Enter now if confident",
    "Volatility-Adjusted Stop Loss Calculated based on RSI (47.3) and current market volatility",
    "Consider scaling out: Take 50% profit at Target 1, 30% at Target 2, let 20% run to Target 3"
   ],
   "facts": {
    "TARGET 1": "$66.69",
    "TARGET 2": "$67.98",
    "TARGET 3": "$69.93",
    "STOP LOSS": "$60.21"
   }
  },
  {
   "id": "seasonality",
   "title": "Seasonal Patterns",
   "text": [
    "Historical monthly performance trends",
    "Based on 3 years of historical monthly returns"
   ],
   "facts": {
    "Average Jan return": "+2.44%",
    "Average Feb return": "-2.31%",
    "Average Mar return": "-2.20%",
    "Average Apr return": "+6.94%",
    "Average May return": "+3.99%",
    "Average Jun return": "+1.20%",
    "Average Jul return": "-3.78%",
    "Average Aug return": "-0.22%",
    "Average Sep return": "+0.78%",
    "Average Oct return": "+1.17%",
    "Average Nov return": "+3.76%",
    "Average Dec return": "-0.27%"
   }
  },
  {
   "id": "risk",
   "title": "Risk & Volatility",
   "facts": {
    "Daily Volatility": "2.22%"
   },
   "lists": {
    "Risk considerations": [
     "Monitor position sizing based on current volatility levels",
     "Consider stop-loss placement beyond recent price range",
     "Diversification helps mitigate single-stock risk exposure"
    ]
   }
  },
  {
   "id": "growth",
   "title": "Growth of $10,000",
   "text": [
    "A $10,000 investment in CNC in September 2016 would be worth about $18,830 today, compared with about $35,241 for the same investment in the S&P 500 benchmark."
   ]
  },
  {
   "id": "monte-carlo",
   "title": "Monte Carlo Projection (10yr)",
   "text": [
    "CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in CNC today could grow to about $19,389 by 2036 in the base case, with a bull case near $98,449 and a bear case around $3,818. Projections are statistical simulations, not guarantees."
   ]
  },
  {
   "id": "price-prediction",
   "title": "CNC Stock Price Prediction: 2030",
   "text": [
    "CleaRank's simulation projects a price near $85.23 for CNC by 2030 in the base case, from $65.40 today (1.3x over 4 years). The downside path ends near $30.50. These are outcomes of a Monte Carlo simulation run on CNC's historical return distribution, not price targets, and they assume no dividends are reinvested.",
    "Method: 10,000 simulated price paths using CNC's historical volatility and drift, re-run daily. The base case is the median path; the two outer columns are the 10th and 90th percentile outcomes, which widen with time because uncertainty compounds. Simulations are not guarantees, and past volatility does not predict future returns. This is analysis, not investment advice."
   ],
   "tables": [
    {
     "caption": "CNC simulated price paths by year",
     "columns": [
      "Year",
      "Downside (10th pct)",
      "Base case",
      "Upside (90th pct)"
     ],
     "rows": [
      {
       "label": "2027",
       "cells": [
        "$41.80",
        "$69.88",
        "$117"
       ]
      },
      {
       "label": "2028",
       "cells": [
        "$36.10",
        "$74.66",
        "$154"
       ]
      },
      {
       "label": "2029",
       "cells": [
        "$32.76",
        "$79.77",
        "$194"
       ]
      },
      {
       "label": "2030",
       "cells": [
        "$30.50",
        "$85.23",
        "$238"
       ]
      },
      {
       "label": "2031",
       "cells": [
        "$28.86",
        "$91.06",
        "$287"
       ]
      },
      {
       "label": "2032",
       "cells": [
        "$27.64",
        "$97.30",
        "$343"
       ]
      },
      {
       "label": "2033",
       "cells": [
        "$26.70",
        "$104",
        "$405"
       ]
      },
      {
       "label": "2034",
       "cells": [
        "$25.97",
        "$111",
        "$475"
       ]
      },
      {
       "label": "2035",
       "cells": [
        "$25.40",
        "$119",
        "$554"
       ]
      },
      {
       "label": "2036",
       "cells": [
        "$24.97",
        "$127",
        "$644"
       ]
      }
     ]
    }
   ]
  },
  {
   "id": "people-also-watch",
   "title": "People Also Watch",
   "links": [
    {
     "text": "ISRG Intuitive Surgical Inc. NASDAQ $358.08 +1.37%",
     "url": "https://clearank.com/stock/intuitive-surgical-isrg/"
    },
    {
     "text": "VEEV Veeva Systems Inc. NYSE $260.98 +0.0690%",
     "url": "https://clearank.com/stock/veev-stock-analysis/"
    },
    {
     "text": "IONS Ionis Pharmaceuticals, Inc. NASDAQ $55.65 -0.6605%",
     "url": "https://clearank.com/stock/ions-stock-analysis/"
    },
    {
     "text": "HIMS Hims & Hers Health, Inc. NYSE $27.52 +0.2733%",
     "url": "https://clearank.com/stock/hims-hers-health-hims/"
    },
    {
     "text": "GILD Gilead Sciences, Inc. NASDAQ $144.81 -0.5767%",
     "url": "https://clearank.com/stock/gilead-sciences-gild/"
    },
    {
     "text": "RXRX Recursion Pharmaceuticals, Inc. NASDAQ $3.20 +1.11%",
     "url": "https://clearank.com/stock/rxrx-stock-analysis/"
    },
    {
     "text": "CRNX Crinetics Pharmaceuticals, Inc. NASDAQ $84.95 +0.00%",
     "url": "https://clearank.com/stock/crinetics-pharmaceuticals-crnx/"
    },
    {
     "text": "REPL Replimune Group, Inc. NASDAQ $13.24 -8.37%",
     "url": "https://clearank.com/stock/repl-stock-analysis/"
    }
   ]
  },
  {
   "id": "related-comparisons",
   "title": "Popular Comparisons",
   "links": [
    {
     "text": "VOO vs SPYM Comparison Head-to-head analysis →",
     "url": "https://clearank.com/compare/voo-vs-splg/"
    },
    {
     "text": "AMAT vs LRCX Comparison Head-to-head analysis →",
     "url": "https://clearank.com/compare/amat-vs-lrcx/"
    },
    {
     "text": "CLS vs SMCI Comparison Head-to-head analysis →",
     "url": "https://clearank.com/compare/cls-vs-smci/"
    }
   ]
  },
  {
   "id": "insider-trading",
   "title": "CNC Insider Trading Analysis",
   "facts": {
    "Bought": "$738.9K",
    "Sold": "$14.6M",
    "Insiders": "18",
    "Avg Transaction": "$2.6M"
   },
   "tables": [
    {
     "caption": "Recent insider transactions in CNC",
     "columns": [
      "Date",
      "Insider",
      "Type",
      "Shares",
      "Value"
     ],
     "rows": [
      {
       "label": "Nov 9, 2020",
       "cells": [
        "NEIDORFF MICHAEL F Chief Executive Officer",
        "Sell",
        "300.0K",
        "$21.0M"
       ]
      },
      {
       "label": "Jun 10, 2026",
       "cells": [
        "BURDICK KENNETH A Director",
        "Sell",
        "80.0K",
        "$5.2M"
       ]
      },
      {
       "label": "Dec 14, 2021",
       "cells": [
        "NEIDORFF MICHAEL F Officer and Director",
        "Sell",
        "50.0K",
        "$4.0M"
       ]
      },
      {
       "label": "Aug 26, 2026",
       "cells": [
        "KOSTER CHRISTOPHER A. General Counsel",
        "Sell",
        "56.5K",
        "$3.8M"
       ]
      },
      {
       "label": "Aug 18, 2026",
       "cells": [
        "KOSTER CHRISTOPHER A. General Counsel",
        "Sell",
        "47.6K",
        "$3.1M"
       ]
      },
      {
       "label": "Dec 4, 2025",
       "cells": [
        "BURDICK KENNETH A Director",
        "Sell",
        "66.0K",
        "$2.6M"
       ]
      },
      {
       "label": "Nov 9, 2020",
       "cells": [
        "BURDICK KENNETH A Officer",
        "Sell",
        "35.0K",
        "$2.5M"
       ]
      },
      {
       "label": "May 11, 2020",
       "cells": [
        "BURDICK KENNETH A Officer",
        "Sell",
        "35.0K",
        "$2.3M"
       ]
      },
      {
       "label": "Apr 30, 2020",
       "cells": [
        "BURDICK KENNETH A Officer",
        "Sell",
        "35.0K",
        "$2.3M"
       ]
      },
      {
       "label": "Jul 30, 2020",
       "cells": [
        "BURDICK KENNETH A Officer",
        "Sell",
        "35.0K",
        "$2.3M"
       ]
      }
     ]
    }
   ],
   "links": [
    {
     "text": "SEC Form 4",
     "url": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&company=Centene+Corp.&type=4&dateb=&owner=include&count=40&search_text=&action=getcompany"
    }
   ]
  },
  {
   "id": "faq",
   "title": "Frequently Asked Questions"
  }
 ],
 "faq": [
  {
   "question": "What is Centene Corp.'s consensus rating and score?",
   "answer": "Centene Corp. (CNC) currently holds a 'Hold' consensus rating with a consensus score of 62 out of 100, based on the analysis of 21 Wall Street analysts."
  },
  {
   "question": "What is the median analyst price target for Centene Corp. stock?",
   "answer": "The median analyst price target for Centene Corp. (CNC) is $70.50, which represents an upside of approximately 10.10% from its current trading price of $64.06."
  },
  {
   "question": "How has Centene Corp. performed in its recent earnings reports?",
   "answer": "Centene Corp. (CNC) reported an EPS of $3.52 for the quarter ending July 23, 2026, beating estimates by 6.02%, though the stock saw a minor decline. Prior quarters showed significant EPS beats, but with varied price reactions, indicating inconsistent investor sentiment towards earnings."
  },
  {
   "question": "What are the key risks facing Centene Corp.?",
   "answer": "Key risks for Centene Corp. (CNC) include moderate insider selling totaling over $14 million and projected revenue declines in the upcoming quarters, which could impact future profitability and growth."
  },
  {
   "question": "Is Centene Corp. stock a buy right now?",
   "answer": "Centene Corp. (CNC) is currently rated as a 'Hold' by Wall Street analysts, with a median price target suggesting limited upside. While the stock trades above its 200-day moving average, it is below its shorter-term moving averages, and faces risks from declining revenue projections and insider selling, making it a neutral prospect at this time."
  },
  {
   "question": "What is the revenue growth outlook for Centene Corp.?",
   "answer": "Centene Corp. (CNC) is projected to experience revenue declines in the current quarter (estimated -6.00% year-over-year) and the next quarter (estimated -9.00% year-over-year). For the current year, revenue growth is estimated at +1.00%, with a slight contraction expected next year."
  },
  {
   "question": "How does Centene Corp.'s valuation compare to its sector averages?",
   "answer": "Centene Corp. (CNC) has a negative EPS, making direct P/E comparison difficult. Its reported revenue growth of 4.6% is below the sector average of 10.00%, suggesting it is growing at a slower pace than its peers in the Healthcare sector."
  },
  {
   "question": "What is CNC's stock forecast for 2030?",
   "answer": "Based on Monte Carlo simulations, Centene Corp.'s (CNC) stock forecast for 2030 shows a base case price of $83.48, with a downside projection of $29.87 and an upside projection of $233.3. These figures represent simulation outcomes, not guaranteed price targets."
  }
 ],
 "related": {
  "peopleAlsoWatch": [
   {
    "ticker": "ISRG",
    "name": "Intuitive Surgical Inc. NASDAQ",
    "price": "$358.08",
    "change": "+1.37%",
    "url": "https://clearank.com/stock/intuitive-surgical-isrg/"
   },
   {
    "ticker": "VEEV",
    "name": "Veeva Systems Inc. NYSE",
    "price": "$260.98",
    "change": "+0.0690%",
    "url": "https://clearank.com/stock/veev-stock-analysis/"
   },
   {
    "ticker": "IONS",
    "name": "Ionis Pharmaceuticals, Inc. NASDAQ",
    "price": "$55.65",
    "change": "-0.6605%",
    "url": "https://clearank.com/stock/ions-stock-analysis/"
   },
   {
    "ticker": "HIMS",
    "name": "Hims & Hers Health, Inc. NYSE",
    "price": "$27.52",
    "change": "+0.2733%",
    "url": "https://clearank.com/stock/hims-hers-health-hims/"
   },
   {
    "ticker": "GILD",
    "name": "Gilead Sciences, Inc. NASDAQ",
    "price": "$144.81",
    "change": "-0.5767%",
    "url": "https://clearank.com/stock/gilead-sciences-gild/"
   },
   {
    "ticker": "RXRX",
    "name": "Recursion Pharmaceuticals, Inc. NASDAQ",
    "price": "$3.20",
    "change": "+1.11%",
    "url": "https://clearank.com/stock/rxrx-stock-analysis/"
   },
   {
    "ticker": "CRNX",
    "name": "Crinetics Pharmaceuticals, Inc. NASDAQ",
    "price": "$84.95",
    "change": "+0.00%",
    "url": "https://clearank.com/stock/crinetics-pharmaceuticals-crnx/"
   },
   {
    "ticker": "REPL",
    "name": "Replimune Group, Inc. NASDAQ",
    "price": "$13.24",
    "change": "-8.37%",
    "url": "https://clearank.com/stock/repl-stock-analysis/"
   }
  ],
  "comparisons": [
   {
    "ticker": "VOO vs SPYM Comparison",
    "name": "",
    "url": "https://clearank.com/compare/voo-vs-splg/"
   },
   {
    "ticker": "AMAT vs LRCX Comparison",
    "name": "",
    "url": "https://clearank.com/compare/amat-vs-lrcx/"
   },
   {
    "ticker": "CLS vs SMCI Comparison",
    "name": "",
    "url": "https://clearank.com/compare/cls-vs-smci/"
   }
  ],
  "sectorHub": {
   "text": "Browse all Healthcare →",
   "url": "https://clearank.com/sector/healthcare/"
  },
  "Newly Tracked": [
   {
    "ticker": "ILMN",
    "text": "Illumina Inc.",
    "url": "https://clearank.com/stock/ilmn-stock-analysis/"
   },
   {
    "ticker": "EXC",
    "text": "Exelon Corp.",
    "url": "https://clearank.com/stock/exc-stock-analysis/"
   },
   {
    "ticker": "GWW",
    "text": "W.W. Grainger Inc.",
    "url": "https://clearank.com/stock/gww-stock-analysis/"
   },
   {
    "ticker": "CDE",
    "text": "Coeur Mining Inc.",
    "url": "https://clearank.com/stock/cde-stock-analysis/"
   },
   {
    "ticker": "CCI",
    "text": "Crown Castle Inc.",
    "url": "https://clearank.com/stock/cci-stock-analysis/"
   }
  ],
  "Top Movers (24h)": [
   {
    "ticker": "MRNA",
    "text": "↑ 8.44%",
    "url": "https://clearank.com/stock/moderna-mrna/"
   },
   {
    "ticker": "REPL",
    "text": "↓ 8.37%",
    "url": "https://clearank.com/stock/repl-stock-analysis/"
   },
   {
    "ticker": "ALGO/USD",
    "text": "↓ 8.21%",
    "url": "https://clearank.com/crypto/algorand-algo-usd/"
   },
   {
    "ticker": "SOXL",
    "text": "↓ 8.03%",
    "url": "https://clearank.com/etf/direxion-semiconductor-bull-soxl/"
   },
   {
    "ticker": "WOLF",
    "text": "↓ 7.73%",
    "url": "https://clearank.com/stock/wolfspeed-wolf/"
   }
  ],
  "Also in Healthcare": [
   {
    "ticker": "CI",
    "text": "The Cigna Group",
    "url": "https://clearank.com/stock/cigna-group-ci/"
   },
   {
    "ticker": "CVS",
    "text": "CVS Health",
    "url": "https://clearank.com/stock/cvs-health-cvs/"
   },
   {
    "ticker": "ELV",
    "text": "Elevance Health",
    "url": "https://clearank.com/stock/elv-stock-analysis/"
   },
   {
    "ticker": "HUM",
    "text": "Humana Inc",
    "url": "https://clearank.com/stock/hum-stock-analysis/"
   },
   {
    "ticker": "MOH",
    "text": "Molina Healthcare Inc.",
    "url": "https://clearank.com/stock/moh-stock-analysis/"
   }
  ]
 },
 "schema": [
  {
   "@context": "https://schema.org",
   "@graph": [
    {
     "@type": "Place",
     "@id": "https://clearank.com/#place",
     "address": {
      "@type": "PostalAddress",
      "streetAddress": "Beni Berman 2",
      "addressLocality": "Netanya",
      "addressRegion": "Center",
      "postalCode": "4249330",
      "addressCountry": "IL"
     }
    },
    {
     "@type": "Organization",
     "@id": "https://clearank.com/#organization",
     "name": "CleaRank",
     "url": "https://clearank.com",
     "sameAs": [
      "https://twitter.com/CleaRank",
      "https://www.linkedin.com/company/clearank/",
      "https://www.youtube.com/@CleaRank"
     ],
     "email": "info@clearank.com",
     "address": {
      "@type": "PostalAddress",
      "streetAddress": "Beni Berman 2",
      "addressLocality": "Netanya",
      "addressRegion": "Center",
      "postalCode": "4249330",
      "addressCountry": "IL"
     },
     "logo": {
      "@type": "ImageObject",
      "@id": "https://clearank.com/#logo",
      "url": "https://clearank.com/wp-content/uploads/2025/02/CleaRank-Logo-e1738621466340.jpg",
      "contentUrl": "https://clearank.com/wp-content/uploads/2025/02/CleaRank-Logo-e1738621466340.jpg",
      "caption": "CleaRank",
      "inLanguage": "en-US",
      "width": "336",
      "height": "153"
     },
     "description": "The CleaRank vision is to bring clarity to the online trading industry and protect trader interests. We use our proprietary technology, expert analysis and verified trader insights, to deliver data driven broker evaluations you can trust. Our CLEAR™ Score is our foundation, a transparent, unbiased methodology that assesses brokers and firms based on the most critical factors including regulation, fees, platform reliability, and real user experiences. We are here to change an unfair system and unlike other review sites that are influenced by partnerships or subjective opinions, CleaRank is 100% independent–abiding by our rigorous CLEAR™ editorial code. We do not accept financial incentives from brokers, so what you see is what you get with no hidden agendas, just honest, actionable feedback. Clear data. Honest reviews. That's the CleaRank promise",
     "numberOfEmployees": {
      "@type": "QuantitativeValue",
      "value": "40"
     },
     "location": {
      "@id": "https://clearank.com/#place"
     }
    },
    {
     "@type": "WebSite",
     "@id": "https://clearank.com/#website",
     "url": "https://clearank.com",
     "name": "CleaRank",
     "publisher": {
      "@id": "https://clearank.com/#organization"
     },
     "inLanguage": "en-US"
    },
    {
     "@type": "ImageObject",
     "@id": "https://clearank.com/wp-content/uploads/2026/07/CNC-centene-analysis-2026-07.png",
     "url": "https://clearank.com/wp-content/uploads/2026/07/CNC-centene-analysis-2026-07.png",
     "width": "1280",
     "height": "720",
     "caption": "Centene (CNC) stock price analysis chart for July 2026",
     "inLanguage": "en-US"
    },
    {
     "@type": "BreadcrumbList",
     "@id": "https://clearank.com/stock/centene-cnc/#breadcrumb",
     "itemListElement": [
      {
       "@type": "ListItem",
       "position": "1",
       "item": {
        "@id": "https://clearank.com",
        "name": "Home"
       }
      },
      {
       "@type": "ListItem",
       "position": "2",
       "item": {
        "@id": "https://clearank.com/stock/centene-cnc/",
        "name": "Centene Corporation (CNC) Stock Analysis"
       }
      }
     ]
    },
    {
     "@type": "WebPage",
     "@id": "https://clearank.com/stock/centene-cnc/#webpage",
     "url": "https://clearank.com/stock/centene-cnc/",
     "name": "Centene (CNC) Stock Forecast & Price Target (2026)",
     "datePublished": "2026-07-26T09:19:58+00:00",
     "dateModified": "2026-09-10T09:13:29+00:00",
     "isPartOf": {
      "@id": "https://clearank.com/#website"
     },
     "primaryImageOfPage": {
      "@id": "https://clearank.com/wp-content/uploads/2026/07/CNC-centene-analysis-2026-07.png"
     },
     "inLanguage": "en-US",
     "breadcrumb": {
      "@id": "https://clearank.com/stock/centene-cnc/#breadcrumb"
     }
    },
    {
     "@type": "Organization",
     "@id": "https://clearank.com/writer/clearank/",
     "name": "CleaRank",
     "description": "CleaRank's vision is to bring clarity to the online trading industry and protecting trader interests by delivering data-driven broker evaluations you can trust.",
     "url": "https://clearank.com/writer/clearank/",
     "image": {
      "@type": "ImageObject",
      "@id": "https://secure.gravatar.com/avatar/4900cf75f960a22a21f1c864e98abc4d5285fa159ea1025d0e8a9db5136e28ef?s=96&d=mm&r=g",
      "url": "https://secure.gravatar.com/avatar/4900cf75f960a22a21f1c864e98abc4d5285fa159ea1025d0e8a9db5136e28ef?s=96&d=mm&r=g",
      "caption": "CleaRank",
      "inLanguage": "en-US"
     },
     "sameAs": [
      "https://clearank.com/",
      "https://twitter.com/CleaRank",
      "https://www.linkedin.com/company/clearank/",
      "https://www.youtube.com/@CleaRank"
     ],
     "worksFor": {
      "@id": "https://clearank.com/#organization"
     },
     "logo": "https://clearank.com/wp-content/uploads/2025/02/CleaRank-Logo-e1738621466340.jpg"
    },
    {
     "@type": "Article",
     "headline": "Centene (CNC) Stock Forecast & Price Target (2026)",
     "datePublished": "2026-07-26T09:19:58+00:00",
     "dateModified": "2026-09-10T09:13:29+00:00",
     "author": {
      "@id": "https://clearank.com/writer/clearank/",
      "name": "CleaRank"
     },
     "publisher": {
      "@id": "https://clearank.com/#organization"
     },
     "description": "Centene Corp. (CNC) stock: Healthcare, Healthcare Plans. $31.6B market cap. AI rating, technicals, 2030 forecast and trade plans.",
     "name": "Centene (CNC) Stock Forecast & Price Target (2026)",
     "@id": "https://clearank.com/stock/centene-cnc/#richSnippet",
     "isPartOf": {
      "@id": "https://clearank.com/stock/centene-cnc/#webpage"
     },
     "image": {
      "@id": "https://clearank.com/wp-content/uploads/2026/07/CNC-centene-analysis-2026-07.png"
     },
     "inLanguage": "en-US",
     "mainEntityOfPage": {
      "@id": "https://clearank.com/stock/centene-cnc/#webpage"
     }
    }
   ]
  },
  {
   "@context": "https://schema.org",
   "@type": "FinancialProduct",
   "name": "Centene Corp. (CNC)",
   "tickerSymbol": "CNC",
   "url": "https://clearank.com/stock/centene-cnc/",
   "description": "AI-powered financial analysis for Centene Corp. (CNC) including technical indicators, market metrics, valuation, and price targets - refreshed daily by CleaRank Financial AI.",
   "exchange": "NYSE",
   "offers": {
    "@type": "Offer",
    "price": 65.4,
    "priceCurrency": "USD",
    "availability": "https://schema.org/InStock",
    "url": "https://clearank.com/stock/centene-cnc/",
    "priceValidUntil": "2026-09-12"
   }
  },
  {
   "@context": "https://schema.org",
   "@type": "FAQPage",
   "mainEntity": [
    {
     "@type": "Question",
     "name": "What is Centene Corp.'s consensus rating and score?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Centene Corp. (CNC) currently holds a 'Hold' consensus rating with a consensus score of 62 out of 100, based on the analysis of 21 Wall Street analysts."
     }
    },
    {
     "@type": "Question",
     "name": "What is the median analyst price target for Centene Corp. stock?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "The median analyst price target for Centene Corp. (CNC) is $70.50, which represents an upside of approximately 10.10% from its current trading price of $64.06."
     }
    },
    {
     "@type": "Question",
     "name": "How has Centene Corp. performed in its recent earnings reports?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Centene Corp. (CNC) reported an EPS of $3.52 for the quarter ending July 23, 2026, beating estimates by 6.02%, though the stock saw a minor decline. Prior quarters showed significant EPS beats, but with varied price reactions, indicating inconsistent investor sentiment towards earnings."
     }
    },
    {
     "@type": "Question",
     "name": "What are the key risks facing Centene Corp.?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Key risks for Centene Corp. (CNC) include moderate insider selling totaling over $14 million and projected revenue declines in the upcoming quarters, which could impact future profitability and growth."
     }
    },
    {
     "@type": "Question",
     "name": "Is Centene Corp. stock a buy right now?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Centene Corp. (CNC) is currently rated as a 'Hold' by Wall Street analysts, with a median price target suggesting limited upside. While the stock trades above its 200-day moving average, it is below its shorter-term moving averages, and faces risks from declining revenue projections and insider selling, making it a neutral prospect at this time."
     }
    },
    {
     "@type": "Question",
     "name": "What is the revenue growth outlook for Centene Corp.?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Centene Corp. (CNC) is projected to experience revenue declines in the current quarter (estimated -6.00% year-over-year) and the next quarter (estimated -9.00% year-over-year). For the current year, revenue growth is estimated at +1.00%, with a slight contraction expected next year."
     }
    },
    {
     "@type": "Question",
     "name": "How does Centene Corp.'s valuation compare to its sector averages?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Centene Corp. (CNC) has a negative EPS, making direct P/E comparison difficult. Its reported revenue growth of 4.6% is below the sector average of 10.00%, suggesting it is growing at a slower pace than its peers in the Healthcare sector."
     }
    },
    {
     "@type": "Question",
     "name": "What is CNC's stock forecast for 2030?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Based on Monte Carlo simulations, Centene Corp.'s (CNC) stock forecast for 2030 shows a base case price of $83.48, with a downside projection of $29.87 and an upside projection of $233.3. These figures represent simulation outcomes, not guaranteed price targets."
     }
    }
   ]
  }
 ]
}